We will welcome over 350 delegates representing leading biotechnology companies, global pharmaceutical organisations, and internationally renowned academic institutions.
Over 30 presentations, case studies and panel discussions focussed on Cell and Gene Therapy development and clinical research, the commercialisation of CAR T treatments, and Cell and Gene Therapy bioprocessing and manufacturing strategies.
3 interactive streams:
Day 1 Stream 1: Cell and Gene Therapy Development and Clinical Trials
Day 1 Stream 2: Cell and Gene Therapy Bioprocessing and Manufacturing Strategies
Day 2 Stream 1: Commercialising Cell and Gene Therapy Treatments
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
Co-located with our highly anticipated 8th Annual Cell Culture and Bioprocessing Congress, 6th Annual Stem Cell and Regenerative Medicine Congress and 2nd Annual Biobanking Congress.
Time: 7:30 am - 5:00 pm
Registration Available from: GBP 299.0
Speakers: Axel Hoos, Senior Vice President and Oncology Therapeutic Area Head, GlaxoSmithKline, Peter Olagunju, Vice President, Patient Operations and Lentiglobin Program Leader, bluebird bio, David Gilham, Vice President, Research and Development, Celyad, Paul Lammers, President and Chief Executive Officer, Triumvira Therapeutics, Soraya Bekkali, Chief Executive Officer, Gyroscope Therapeuticsmore
- Mayo Clinic Advanced Body MRI COURSE HIGHLIGHTS • State of the art MR techniques for musc...
- Fifteenth Eilat Conference on New Antiepileptic Drugs and Devices For the forthcoming conference, we will be continuing with debate...
- Cytovance® Biologics Cytovance® Biologics is a contract development and manufacturing organization specialising in mammal...
- Industry Leading Experts in a Global Pharmaceutical Industry – Providing you with Solutions across the Product Life Cycle NSF Health Sciences Pharma Biotech Consulting provides a comprehensive range of support services for...